Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells

FEBS Lett. 2009 Jan 22;583(2):425-9. doi: 10.1016/j.febslet.2008.12.041. Epub 2008 Dec 29.

Abstract

The genetic basis for the Ara-C resistance of CCRF-CEM Ara-C/8C leukemia cells was investigated. DNA sequencing revealed that these cells expressed an equilibrative nucleoside transporter 1 (ENT1) with a single missense mutation resulting in glycine to arginine replacement (G24R). To test the importance of this residue, additional G24 mutants were created and examined for [3H]-uridine and [3H]-Ara-C uptake. Both a G24E and G24A mutant showed reduced ENT1-dependent activity. An EGFP-tagged G24R ENT1 displayed plasma membrane localization even though it was unable to bind [3H]-NBMPR, an ENT1-specific inhibitor. These results define G24 as critical amino acid for ENT1 nucleoside uptake and suggest that mutations in TM1 may provide a mechanism for Ara-C resistance in CCRF-CEM Ara-C/8C cells.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antimetabolites, Antineoplastic / pharmacology*
  • Cell Line, Tumor
  • Cell Membrane / metabolism
  • Cytarabine / pharmacology*
  • Drug Resistance, Neoplasm / genetics*
  • Equilibrative Nucleoside Transporter 1 / genetics*
  • Equilibrative Nucleoside Transporter 1 / metabolism
  • Glycine / genetics
  • Glycine / metabolism
  • Humans
  • Leukemia, T-Cell / metabolism*
  • Molecular Sequence Data
  • Point Mutation
  • Protein Structure, Tertiary / genetics
  • RNA, Messenger / biosynthesis
  • Thioinosine / analogs & derivatives
  • Thioinosine / metabolism

Substances

  • Antimetabolites, Antineoplastic
  • Equilibrative Nucleoside Transporter 1
  • RNA, Messenger
  • SLC29A1 protein, human
  • Cytarabine
  • Thioinosine
  • 4-nitrobenzylthioinosine
  • Glycine